Capecitabine (C) in combination with cisplatin (P) for recurrent and/or metastatic squamous cell carcinoma of head and neck (HN)

被引：0
|
作者：
Lopez-Argumedo, Gonzalo [1 ]
Perez-Hoyos, Teresa [1 ]
Rubio, Itziar [1 ]
Munoz, Alberto [1 ]
Mane, Joan M. [1 ]
Viteri, Ainhoa [1 ]
Pardo, Marta [1 ]
Barcelo, Ramon [1 ]
Martinez, Alejandro [1 ]
Lopez-Vivanco, Guillermo [1 ]
机构：
[1] Hosp Cruces, Baracaldo, Spain
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Capecitabine and cisplatin combination chemotherapy as salvage therapy for recurrent unresectable or metastatic squamous cell carcinoma of the head and neck
    Chung, J.
    Cho, G.
    Shin, H.
    Choi, Y.
    Lee, S.
    Lee, B.
    Wang, S.
    Lee, M.
    Sohn, C.
    Yang, Y.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [2] A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Won, Y. -W.
    Park, Y. H.
    Ahn, M. J.
    Do, I. -G.
    Ko, Y. H.
    Park, K.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (02) : 417 - 423
  • [3] DOXORUBICIN AND CISPLATIN FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    SANDLER, S
    BONOMI, P
    TAYLOR, B
    SHOWEL, J
    SLAYTON, R
    LERNER, H
    [J]. CANCER TREATMENT REPORTS, 1984, 68 (09): : 1163 - 1165
  • [4] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    [J]. ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
  • [5] Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck
    Thodtmann, R
    Theiss, F
    Kemmerich, M
    Heinrich, B
    Laubenbacher, C
    Quasthoff, S
    Kau, R
    Herzog, M
    Diergarten, K
    Hanauske, AR
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (03) : 335 - 337
  • [6] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [7] VINBLASTINE, BLEOMYCIN AND CISPLATIN FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    PERRY, DJ
    WELTZ, MD
    BROWN, AW
    HENDERSON, RL
    NEGLIA, WJ
    BERENBERG, JL
    [J]. CANCER, 1982, 50 (11) : 2257 - 2260
  • [8] Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
    Chen, W-C.
    Chang, P. M-H.
    Lee, Y-T.
    Lu, W-B.
    Yang, M-H.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] The triplet docetaxel, carboplatin and capecitabine in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN).
    Kattan, J
    Farhat, F
    Chahine, G
    Nasr, F
    Moukadem, W
    Younes, F
    Ghosn, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 521S - 521S
  • [10] Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma
    Peron, Julien
    Poupart, Marc
    Ceruse, Philippe
    Ramade, Antoine
    Girodet, Didier
    Zrounba, Philippe
    Fayette, Jerome
    [J]. ANTI-CANCER DRUGS, 2012, 23 (10) : 1107 - 1111
12345